Alterity Therapeutics Ltd Capital Reinvestment Ratio

Latest as of September 2023: 0.01x

Alterity Therapeutics Ltd capital reinvestment ratio. Alterity Therapeutics Ltd (ATHE) has a Capital Reinvestment Ratio of 0.01x as of September 2023, meaning it reinvests 0% of its operating cash flow ($549.00K) in capital expenditures ($4.00K). Check Alterity Therapeutics Ltd (ATHE) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$549.00K

USD

Capital Expenditures

$4.00K

USD

Data as of

Sep 2023

Most recent filing

Alterity Therapeutics Ltd Capital Reinvestment Ratio by Year (None–None)

Alterity Therapeutics Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash flow conversion of Alterity Therapeutics Ltd.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow